{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:19:53Z","timestamp":1773980393140,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report the outcomes of the 0.18 mg fluocinolone acetonide insert (FAi) in the treatment of chronic (&gt;6 months) postoperative cystoid macular edema after cataract surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective consecutive case series of eyes with chronic postoperative cystoid macular edema treated with the FAi. Visual acuity, intraocular pressure, optical coherence tomography metrics, and supplemental therapies were extracted from the charts before and at 3, 6, 12, 18, and 21 months after FAi placement, when available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nineteen eyes of 13 patients with chronic postoperative cystoid macular edema after cataract surgery underwent FAi placement with an average follow-up of 15.4 months. Ten eyes (52.6%) had a \u22652-line gain in visual acuity. Sixteen eyes (84.2%) had a \u226520% reduction in optical coherence tomography central subfield thickness. Eight eyes (42.1%) had complete resolution of CME. Improvements in central subfield thickness and visual acuity were sustained throughout individual follow-up. Compared with 18 eyes (94.7%) requiring local corticosteroid supplementation before FAi, only six eyes (31.6%) required supplementation after FAi. Similarly, of the 12 eyes (63.2%) that were on corticosteroid drops before FAi, only 3 (15.8%) required drops after FAi.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Eyes with chronic postoperative cystoid macular edema after cataract surgery treated with the FAi had improved and sustained visual acuity and optical coherence tomography metrics, along with a reduction in supplemental treatment burden.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003765","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T22:01:12Z","timestamp":1676584872000},"page":"897-904","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["0.18 MG FLUOCINOLONE ACETONIDE INSERT FOR THE TREATMENT OF CHRONIC POSTOPERATIVE PSEUDOPHAKIC CYSTOID MACULAR EDEMA"],"prefix":"10.1097","volume":"43","author":[{"given":"Jordan D.","family":"Deaner","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Mammo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn J.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilraj S.","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9394(53)90302-X","article-title":"A newly defined vitreous syndrome following cataract surgery","volume":"36","author":"Irvine","year":"1953","journal-title":"Am J Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","article-title":"Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study","volume":"76","author":"Gass","year":"1966","journal-title":"Arch Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000320078","article-title":"Postsurgical cystoid macular edema","volume":"47","author":"Loewenstein","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jcrs.2007.05.013","article-title":"Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment","volume":"33","author":"Henderson","year":"2007","journal-title":"J Cataract Refractive Surg"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000073070","article-title":"Incidence of cystoid macular edema after uncomplicated phacoemulsification","volume":"217","author":"Mentes","year":"2003","journal-title":"Ophthalmologica"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/02713680601160610","article-title":"Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography","volume":"32","author":"Perente","year":"2007","journal-title":"Curr Eye Res"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1442-9071.2011.02638.x","article-title":"Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco-emulsification cataract surgery","volume":"40","author":"Vukicevic","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10792-014-9998-5","article-title":"Study of cystoid macular edema by optical coherent tomography following uneventful cataract surgery","volume":"35","author":"Chaudhary","year":"2015","journal-title":"Int Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/IAE.0b013e318169d04e","article-title":"A method of reporting macular edema after cataract surgery using optical coherence tomography","volume":"28","author":"Kim","year":"2008","journal-title":"Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1080\/09273948.2019.1634215","article-title":"Incidence of irvine Gass syndrome after phacoemulsification with spectral-domain optical coherence tomography","volume":"27","author":"Bellocq","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.survophthal.2014.08.005","article-title":"Management of pseudophakic cystoid macular edema","volume":"60","author":"Guo","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00006982-198808030-00001","article-title":"Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation","volume":"8","author":"Bradford","year":"1988","journal-title":"Retina"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0161-6420(00)00365-1","article-title":"Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema","volume":"107","author":"Heier","year":"2000","journal-title":"Ophthalmology"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","article-title":"A comparison of retrobulbar versus sub-Tenon\u2019s corticosteroid therapy for cystoid macular edema refractory to topical medications","volume":"104","author":"Thach","year":"1997","journal-title":"Ophthalmology"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema","volume":"29","author":"Conway","year":"2003","journal-title":"J Cataract Refractive Surg"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmologica Scand"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/IAE.0b013e31802e3e5c","article-title":"Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study","volume":"27","author":"Koutsandrea","year":"2007","journal-title":"Retina"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/eye.2016.205","article-title":"Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series","volume":"30","author":"Sudhalkar","year":"2016","journal-title":"Eye"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jcrs.2015.10.025","article-title":"Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome","volume":"41","author":"Mayer","year":"2015","journal-title":"J Cataract Refractive Surg"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000448057","article-title":"Intravitreal dexamethasone implant for the treatment of postoperative macular edema","volume":"236","author":"Klamann","year":"2016","journal-title":"Ophthalmologica"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.therap.2016.01.009","article-title":"Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: a retrospective study of six cases","volume":"71","author":"Keilani","year":"2016","journal-title":"Therapies"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","article-title":"Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study","volume":"99","author":"Bellocq","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R25-20250605","first-page":"333","article-title":"Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study","volume":"101","author":"Bellocq","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2011.05.028","article-title":"Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography","volume":"152","author":"Sugar","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/j.jcrs.0000000000000908","article-title":"Ocular injectable treatment options for postcataract macular edema: systematic review","volume":"48","author":"Ahmadyar","year":"2022","journal-title":"J Cataract Refractive Surg"},{"key":"R29-20250605","first-page":"127","article-title":"Fluocinolone acetonide 0.19 mg implant in patients with cystoid macular edema due to irvine-gass syndrome","volume":"14","author":"Marques","year":"2021","journal-title":"Int Med Case Rep J"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000464259","article-title":"Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes","volume":"237","author":"Hattenbach","year":"2017","journal-title":"Ophthalmologica"},{"key":"R31-20250605","doi-asserted-by":"crossref","first-page":"NP23","DOI":"10.1177\/11206721211046718","article-title":"Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes","volume":"33","author":"Miguel-Escuder","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R32-20250605","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/ICB.0000000000000779","article-title":"Bilateral intravitreal 0.19-MG fluocinolone acetonide implant for persistent nondiabetic cystoid macular edema after vitrectomy","volume":"15","author":"Ong","year":"2021","journal-title":"Retinal Cases Brief Rep"},{"key":"R33-20250605","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00417-020-04614-x","article-title":"Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant","volume":"258","author":"Cai","year":"2020","journal-title":"Graefe's Archive Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:05:00Z","timestamp":1749143100000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003765","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}